Back to Search
Start Over
PEGylated Platinum Nanoparticles: A Comprehensive Study of Their Analgesic and Anti-Inflammatory Effects.
- Source :
-
ACS applied bio materials [ACS Appl Bio Mater] 2025 Jan 20; Vol. 8 (1), pp. 628-641. Date of Electronic Publication: 2025 Jan 02. - Publication Year :
- 2025
-
Abstract
- Pain and inflammation are common symptoms of a majority of the diseases. Chronic pain and inflammation, as well as related dreadful disorders, remain difficult to control due to a lack of safe and effective medications. In this work, biocompatible platinum nanoparticles with significant analgesic and anti-inflammatory action were synthesized through a wet chemical method using polyethylene glycol-400 as a capping agent and sodium borohydride as a reducing agent. The average particle size of these Pt nanospheres was determined to be 3.26 nm using TEM analysis, and X-ray diffraction confirmed their face-centered cubic crystalline structure. Fourier transform infrared and UV-visible spectroscopy confirm that Pt-NPs are coated with the PEG-400 molecule. The significantly negative zeta potential value (-26.8 mV) indicates the stability of the produced nanoparticles. In vitro cytotoxicity studies on normal cell lines show nontoxic behavior with over 96% cell viability at 100 μg/mL of the test sample. In vitro assays of inhibition of protein denaturation and DPPH free radical scavenging elucidated the anti-inflammatory and antioxidant properties of PEGylated Pt NPs with promising EC <subscript>50</subscript> values 57.99 and 9.324 μg/mL, respectively. In vivo animal trials confirmed that PEG-capped Pt-NPs are more effective than conventional medicines. The in vivo hot plate assay for the analgesic study shows a maximum response time of 14.5 ± 1.22 s (92.54% analgesia) at a dosage of 50 mg/kg and 13.8 ± 0.71 s (86.05% analgesia) at a dosage of 25 mg/kg after 180 and 240 min of administration, respectively. In the rat paw edema model for anti-inflammatory activity, the PEG-capped Pt NPs exhibit significant inhibitory action, with the maximum percentage of edema inhibition at a dosage of 50 mg/kg identical to that of the aspirin-based standard medication administered at a higher dosage of 100 mg/kg, resulting in 42% inhibition, suggesting a versatile solution for inflammation and persistent pain.
- Subjects :
- Animals
Rats
Edema drug therapy
Edema chemically induced
Cell Survival drug effects
Materials Testing
Biocompatible Materials chemistry
Biocompatible Materials pharmacology
Biocompatible Materials chemical synthesis
Male
Humans
Mice
Rats, Wistar
Metal Nanoparticles chemistry
Platinum chemistry
Platinum pharmacology
Analgesics chemistry
Analgesics pharmacology
Polyethylene Glycols chemistry
Particle Size
Anti-Inflammatory Agents chemistry
Anti-Inflammatory Agents pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 2576-6422
- Volume :
- 8
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- ACS applied bio materials
- Publication Type :
- Academic Journal
- Accession number :
- 39746938
- Full Text :
- https://doi.org/10.1021/acsabm.4c01498